GHAPPcast4 Sep 2024

FAQ: What is the Difference Between Biosimilars and Generics?

Thank you to Boehringer Ingelheim for your support of this FAQ Video Module.

Join Tedra Gray, NP, as she explains how biosimilars and generics play a crucial role in modern medicine, especially in fields like gastroenterology, rheumatology, and dermatology. She explains the key differences between biosimilars and generic medications, helping both healthcare providers and patients make informed treatment decisions.

Generic medications are identical copies of brand-name drugs, containing the same active ingredients, dosage, and route of administration. These drugs are FDA-approved and become available once the patent for the original brand-name drug expires. On the other hand, biosimilars are highly similar but not identical to biologic drugs, which are derived from living organisms or cells. These medications are often used to treat complex diseases like inflammatory bowel disease (IBD), Crohn’s disease, and ulcerative colitis. While biosimilars must demonstrate no clinically meaningful differences in pharmacokinetics or pharmacodynamics, they are not exact replicas like generics due to the complexity of biologic drugs.

For gastroenterology patients and providers, understanding the differences between biosimilars and generics is essential when choosing effective treatment options. Whether managing chronic GI conditions or exploring cost-effective alternatives, recognizing these distinctions ensures better patient care. For more information on biosimilars, generics, and GI treatment strategies, visit the GHAPP website or GHAPP ACE 2.0 mobile app to stay informed and empowered in your healthcare journey!

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(154)

Medication Review: Guselkumab IV vs SC Formulation

Thank you to Johnson & Johnson for their support on this Medication Review Video Module. In this quick educational video, Angelina Collins, NP, from the University of California San Diego Inflammatory...

28 Mai 3min

FAQ: Recognizing OHE Risk in Patients with Chronic Liver Disease

Thank you to Salix for the support on this FAQ Video Module.This educational FAQ module, featuring Mikhail Alper, PA-C focuses on recognizing risk factors and early clinical indicators of Overt Hepati...

26 Mai 2min

FAQ: Phase 3 GALAXI 2 & 3: Extraintestinal Manifestations In Moderate to Severe Crohn’s Disease

Thank you to Johnson & Johnson for the support on this FAQ Video Module.This FAQ video features Janette Villalon, PA, who reviews the role of guselkumab in treating extraintestinal manifestations in p...

19 Mai 5min

Medication Review: Monotherapy vs. Combination Therapy: Relevance in IBD Treatment Strategy

Thank you to Celltrion for the support on this Medication Review Video Module.This medication review explores the evolving role of monotherapy versus combination therapy in the treatment of inflammato...

14 Mai 3min

Medication Review: Stable PK Supporting Continuous Inflammatory Control

Thank you to Celltrion for the support on this Medication Review Video Module.This medication review explores the role of stable pharmacokinetics (PK) in achieving continuous inflammatory control in i...

7 Mai 6min

Journal Club: ASTRO Phase 3 Study: Efficacy and Safety of SC Guselkumab

Thank you to Johnson & Johnson for the support on this Journal Club Review Module.In this journal club video, Sharon Dudley Brown, CRNP, PhD, from the IBD Center at Johns Hopkins University, reviews t...

28 Apr 5min

Journal Club: Benefit–Risk Profile of Upadacitinib in Patient’s With Moderate to Severe UC and CD

Thank you to AbbVie for the support on this Journal Club Review Module.This journal club review episode explores the benefit–risk profile of Upadacitinib for patients with moderately to severely activ...

21 Apr 23min

Podcast: How Do You Best Support Patients Getting Started on New MASH Treatments?

Learn how to effectively support patients starting treatment for MASH with this practical, clinician-focused discussion featuring expert advanced practice providers. In this episode, hepatology specia...

14 Apr 18min